MentionFox
Home › Executive changes › Ventyx Biosciences, Inc.
Leadership changes · VTYX · SEC Form 8-K, Item 5.02

Leadership changes at Ventyx Biosciences, Inc. (2026)

Before you join, sell to or invest in Ventyx Biosciences, Inc.

MentionFox check on Ventyx Biosciences, Inc.: only 1 source on file so far (checked 14 November 2026). Run a full check before you rely on it. mentionfox.com/c/executive-changes/ventyx-biosciences

Check Ventyx Biosciences, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Ventyx Biosciences, Inc.?

Who joined and who left Ventyx Biosciences, Inc. (VTYX)? 1 filing reported on 2026-03-04, each cited to the company's own filing.

As of November 14, 2026, Ventyx Biosciences, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on March 4, 2026 (Form 8-K, March 4, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

Affinity Asset Advisors, LLC also filed stake reports on 16 other companies ↓

Sell to companies like Ventyx Biosciences, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes1
Latest filing2026-03-04

Ventyx Biosciences, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-03-04. Every row below is cited to the filing it comes from, and this page adds each new change as Ventyx Biosciences, Inc. files it.

Also on the record for Ventyx Biosciences, Inc.

DateRecordFigureOur pageSource
May 15, 2026Stake report, Schedule 13G/A, by TANG CAPITAL MANAGEMENT, LLC—5%+ stakesSource
May 14, 2026Stake report, Schedule 13G/A, by Affinity Asset Advisors, LLC—5%+ stakesSource
May 14, 2026Stake report, Schedule 13G/A, by Glazer Capital, LLC—5%+ stakesSource
March 5, 2026Stake report, Schedule 13D/A, by Subramaniam Somu—5%+ stakesSource
March 4, 2026Acquired by Eli Lilly and Company$1.20BAcquisitionSource
February 19, 2026Stake report, Schedule 13G, by Glazer Capital, LLC6.23% of the class5%+ stakesSource
February 6, 2026Stake report, Schedule 13G/A, by Morgan Stanley0.3% of the class5%+ stakesSource
February 5, 2026Stake report, Schedule 13G, by Morgan Stanley6% of the class5%+ stakesSource
January 29, 2026Stake report, Schedule 13G/A, by Affinity Asset Advisors, LLC9% of the class5%+ stakesSource
January 9, 2026Stake report, Schedule 13D/A, by Raju Mohan6% of the class5%+ stakesSource
January 9, 2026Stake report, Schedule 13D/A, by Subramaniam Somu5.8% of the class5%+ stakesSource
November 26, 2025Stake report, Schedule 13D, by Raju Mohan6% of the class5%+ stakesSource

Selling to them or working with them? See who runs Ventyx Biosciences, Inc. now and the warning signs.

Free to see. No signup.

Keep reading

More on Ventyx Biosciences, Inc. and the records around it.

Ventyx Biosciences, Inc. elsewhere on the record

Companies that share a holder

Want the whole picture on Ventyx Biosciences, Inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Ventyx Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Ventyx Biosciences, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    12 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The newest 12 of 16 records.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-03-04Reportednot named in the filing8-K, 2026-03-04
Selling to Ventyx Biosciences, Inc.?

New leaders reset buying decisions — get the Full Report on Ventyx Biosciences, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Ventyx Biosciences, Inc.

Hiring for a seat like this?

Find people with the same kind of experience as the senior executive at Ventyx Biosciences, Inc., with the record behind each one.

Find candidates like senior executive at Ventyx Biosciences, Inc.

Every change, in the filing's words

Filed 2026-03-04 · 8-K

Reported

In accordance with the terms of the Merger Agreement, at the Effective Time, Onaiza Cadoret-Manier, Sheila Gujrathi, Allison Hulme, Raju Mohan, Somu Subramaniam, and William White, each of whom was a director of the Company as of immediately prior to the Effective Time, resigned and ceased to be a director of the Company and a member of any committee of the Company's Board of Directors.

Also stated in this filing

  • In accordance with the terms of the Merger Agreement, at the Effective Time, Christopher Anderson, Jonathan R. Haug and Sherry D. Davis, the directors of Merger Sub immediately prior to the Effective Time, became directors of the Company.
  • In accordance with the terms of the Merger Agreement, at the Effective Time, Raju Mohan, Mark Forman, Roy Gonzales, Matthew Moore and John Nuss resigned from their positions as officers of the Company.
  • In accordance with the terms of the Merger Agreement, at the Effective Time, the officers of Merger Sub immediately prior to the Effective Time, Jonathan R. Haug as President, Steffanie Lim-Ho as Treasurer, Christopher Anderson as Secretary, Jonathan Groff as Assistant Secretary and Katie Lodato as Assistant Treasurer, became the officers of the Company.

Tools for this story

Each opens in a new tab, filled in for Ventyx Biosciences, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/ventyx-biosciences
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
What changed at the top of Ventyx Biosciences, Inc.? (2026). MentionFox, 2026-11-14. https://mentionfox.com/executive-changes/ventyx-biosciences